For Patients
Find essential information here about ovarian cancer prevention, risk factors, and steps to take if you’ve been newly diagnosed, in treatment or navigating life beyond.
The Rivkin Center Has Joined OCRA
The Rivkin Center Has Joined OCRA
This historic collaboration unites two respected organizations committed to advancing research for better treatments and a cure for ovarian cancer.
Expanding Research Through Partnership
Ovarian Cancer Research Alliance (OCRA), the world’s leading ovarian and gynecologic cancer nonprofit, is proud to announce that the Rivkin Center for Ovarian Cancer Research has combined with OCRA.
Please explore the resources below to learn more about the support and tools available from OCRA.
Support The Rivkin Pilot Grant
The Rivkin Pilot Grant paves the way for innovative breakthroughs in all areas of ovarian cancer research. OCRA is proud to continue the Rivkin Center’s extraordinary legacy of hope, determination, and relentless pursuit of a cure.
Support & Resources
OCRA is here for you and your family to answer questions or connect you with resources to help you and offer support.
Research
OCRA has awarded more than 400 grants and invested $128 million in ovarian cancer and related gynecologic cancer research initiatives, becoming the largest global charity devoted to ovarian and related gynecologic cancer research in the world.
Center for Public Policy
OCRA advocates on Capitol Hill to improve research and education, drug and diagnostic safety, and access to quality care for all members of the ovarian and gynecologic cancer community, having helped secure $3.8 billion in federal research and education funding since inception..
Get Involved
Help us get one step closer to a cure. There are so many ways to lend a hand and improve the lives of patients and families impacted by ovarian and all gynecologic cancers.
OCRA Rivkin Family SummeRun
On July 13, 2025, join thousands of participants of all ages and fitness levels at Seattle’s Seward Park to raise awareness and fund critical research for ovarian cancer. Funds raised will support The Rivkin Pilot Grant. Registration opens in early April.
About
OCRA is the leading organization in the world fighting ovarian and all gynecologic cancers on all fronts while supporting patients and their families.
Related Topics
The Overview: November 2025
Friends, As we approach the end of the year, one thing stands out above all else: this is a moment of unprecedented opportunity to accelerate progress against ovarian and all gynecologic cancers. And thanks to you, OCRA is rising to meet that moment — driving innovation, expanding support, and providing the community that so many … Continued
OCRA Board Member Laura Shawver, PhD, Named to Fierce 50 of 2025
Ovarian Cancer Research Alliance (OCRA) congratulates board member Laura Shawver, PhD, on her selection to the Fierce 50 of 2025, a leading industry award from Fierce Life Sciences recognizing individuals and organizations advancing what’s possible in health, science and patient care. Dr. Shawver was selected for her long-standing leadership in oncology research and drug development, … Continued
Make 2X the Difference with OCRA on GivingTuesday
On GivingTuesday, YOU Can Help Shape the Future of Ovarian and Gynecologic Cancer Care GivingTuesday gifts—including early gifts—will be matched by a generous OCRA board member, dollar for dollar, up to $500,000. That means your $1 = $2 to improve care, foster hope, and bring us closer to a cure. Ovarian Cancer Research Alliance (OCRA) … Continued